TAKE last traded at ₹12.69 (2026-10-13). Over the past month the stock moved -25.0%, three months the stock moved -58.7%, year the stock moved +19.8%. Its closing range over 52 weeks is ₹11.60 – ₹48.91, with the latest close 74.1% below the high.
Closing prices up to 2026-10-13.
Incorporated in 2000, TAKE Solutions Ltd is in the business of Life Sciences and Support Services[1]
Business Overview:[1] Singapore-based TAKE Solutions Pte Limited holds a 52.90% stake in TSL, serving as the holding company. TSL specializes in Life Sciences and Supply Chain Management, providing comprehensive services in clinical development and specific offerings in supply chain. The company is involved in clinical trials, generics support, including bio-availability & bioequivalent studies, regulatory filing, and pharmacovigilance.
In the latest quarter (Jun 2026), TAKE reported sales of ₹30.37 crore and net profit of ₹1.06 crore, compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 30.37 | -0.27 | -0.89 | 1.06 | 0.07 |
| Mar 2026 | 54.19 | -0.82 | -1.51 | 4.36 | 0.29 |
| Dec 2025 | 0.00 | -0.35 | – | 1.11 | 0.08 |
| Sep 2025 | 0.00 | -0.30 | – | 6.29 | 0.43 |
| Jun 2025 | 0.00 | -0.44 | – | -0.91 | -0.06 |
| Mar 2025 | 0.00 | -1.15 | – | -4.88 | -0.33 |
| Dec 2024 | 0.00 | -2.89 | – | 47.68 | 3.22 |
| Sep 2024 | 0.00 | -0.90 | – | -1.58 | -0.11 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | -100.0% | – | – | – | – | – | – | – |
| Operating profit growth | – | – | – | – | – | – | – | – |
| Net profit growth | – | – | – | – | – | -97.7% | – | – |
| EPS growth | – | – | – | – | – | -97.5% | – | – |
| OPM % | – | – | – | – | – | – | -1.5% | -0.9% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
In the latest year (Mar 2026), TAKE reported sales of ₹54.00 crore and net profit of ₹11.00 crore (-70.3%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 54.00 | -2.00 | -4.00 | 11.00 | 0.73 |
| Mar 2025 | 0.00 | -7.00 | – | 37.00 | 2.53 |
| Mar 2024 | 66.00 | -13.00 | -20.00 | -120.00 | -8.09 |
| Mar 2023 | 189.00 | -19.00 | -10.00 | -100.00 | -6.78 |
| Mar 2022 | 655.00 | 7.00 | 1.00 | -782.00 | -52.88 |
| Mar 2021 | 774.00 | -73.00 | -9.00 | -450.00 | -30.56 |
| Mar 2020 | 2,213 | 169.00 | 8.00 | -11.00 | -0.84 |
| Mar 2019 | 2,039 | 384.00 | 19.00 | 178.00 | 11.99 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +28.5% | +8.5% | -65.0% | -15.4% | -71.1% | -65.1% | -100.0% | – |
| Operating profit growth | +25.1% | -56.0% | -143.2% | – | -371.4% | – | – | – |
| Net profit growth | +11.3% | -106.2% | – | – | – | – | – | -70.3% |
| EPS growth | +10.5% | -107.0% | – | – | – | – | – | -71.1% |
| OPM % | 19.0% | 8.0% | -9.0% | 1.0% | -10.0% | -20.0% | – | -4.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for TAKE.
Get Free AI Stock Analysis FREE →Rupee Depreciation: RBI Steps In To Take OMCs Away From Spot Market, Tightens Derivative Trades
Real estate stocks take a battering amid RBI's rate hike, changed stance - Moneycontrol.com
Real estate stocks take a battering amid RBI's rate hike, changed stance - Moneycontrol.com
‘Increase maximum EDLI benefit to Rs 10.50 lakh’: Why this BJP MP wants government to take immediate actio - The Economic Times
Saudi Aramco chief says replenishing global oil stockpiles could take two years - Forex Factory
US stocks: US market opens muted as tech stocks take a breather - The Economic Times
Saudi Aramco CEO warns oil stocks drained by Iran war could take 2 years to rebuild
Saudi Aramco chief says replenishing global oil stockpiles could take two years - CNBC
Take action: SC to Allahabad HC chief justice on allegations against Lakhimpur Kheri case judge - The Economic Times
Indian bonds take a breather before RBI policy outcome - The Economic Times
TAKE shares were last quoted at ₹12.69 (-4.9% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
TAKE has a price-to-earnings (P/E) ratio of 17.43 and a price-to-book (P/B) ratio of 6.99. The industry P/E is 102.59.
The 52-week high of TAKE is ₹49.90 and the 52-week low is ₹10.35.
The market capitalisation of TAKE is about ₹224.27 crore.
In the latest quarter (Jun 2026), TAKE reported sales of ₹30.37 crore and net profit of ₹1.06 crore, compared with the same quarter last year.
This page is for information and is not investment advice. As per the data shown here, TAKE has a 3-year ROE of -47.00%, 3-year profit growth of 27.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Promoters hold about 5.19% of TAKE.
TAKE belongs to the Pharmaceuticals & Drugs sector.